These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36380755)

  • 21. High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples.
    Pater AA; Bosmeny MS; White AA; Sylvain RJ; Eddington SB; Parasrampuria M; Ovington KN; Metz PE; Yinusa AO; Barkau CL; Chilamkurthy R; Benzinger SW; Hebert MM; Gagnon KT
    J Biol Methods; 2021; 8(COVID 19 Spec Iss):e155. PubMed ID: 34631911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust Mutation Profiling of SARS-CoV-2 Variants from Multiple Raw Illumina Sequencing Data with Cloud Workflow.
    Lim HG; Hsiao SH; Fann YC; Lee YG
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples.
    Kubik S; Marques AC; Xing X; Silvery J; Bertelli C; De Maio F; Pournaras S; Burr T; Duffourd Y; Siemens H; Alloui C; Song L; Wenger Y; Saitta A; Macheret M; Smith EW; Menu P; Brayer M; Steinmetz LM; Si-Mohammed A; Chuisseu J; Stevens R; Constantoulakis P; Sali M; Greub G; Tiemann C; Pelechano V; Willig A; Xu Z
    Clin Microbiol Infect; 2021 Jul; 27(7):1036.e1-1036.e8. PubMed ID: 33813118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of EPISEQ SARS-CoV-2 and a Fully Integrated Application to Identify SARS-CoV-2 Variants from Several Next-Generation Sequencing Approaches.
    Mugnier N; Griffon A; Simon B; Rambaud M; Regue H; Bal A; Destras G; Tournoud M; Jaillard M; Betraoui A; Santiago E; Cheynet V; Vignola A; Ligeon V; Josset L; Brengel-Pesce K
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mini-XT, a miniaturized tagmentation-based protocol for efficient sequencing of SARS-CoV-2.
    Fuchs M; Radulescu C; Tang M; Mahesh A; Lavin D; Umbreen S; McKenna J; Smyth M; McColgan E; Molnar Z; Baxter C; Skvortsov T; Singh A; Rogan F; Miskelly J; Bridgett S; Fairley D; Simpson DA
    J Transl Med; 2022 Mar; 20(1):105. PubMed ID: 35241105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern.
    Daviña-Núñez C; Pérez S; Cabrera-Alvargonzález JJ; Rincón-Quintero A; Treinta-Álvarez A; Godoy-Diz M; Suárez-Luque S; Regueiro-García B
    PLoS One; 2024; 19(4):e0289188. PubMed ID: 38683803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing genomic variant identification protocols for
    Li X; Muñoz JF; Gade L; Argimon S; Bougnoux ME; Bowers JR; Chow NA; Cuesta I; Farrer RA; Maufrais C; Monroy-Nieto J; Pradhan D; Uehling J; Vu D; Yeats CA; Aanensen DM; d'Enfert C; Engelthaler DM; Eyre DW; Fisher MC; Hagen F; Meyer W; Singh G; Alastruey-Izquierdo A; Litvintseva AP; Cuomo CA
    Microb Genom; 2023 Apr; 9(4):. PubMed ID: 37043380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing.
    Arévalo MT; Karavis MA; Katoski SE; Harris JV; Hill JM; Deshpande SV; Roth PA; Liem AT; Bernhards RC
    Front Microbiol; 2022; 13():910955. PubMed ID: 35733956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Whole-Genome Sequencing Using Oxford Nanopore Technology for Variant Monitoring in Wastewaters.
    Barbé L; Schaeffer J; Besnard A; Jousse S; Wurtzer S; Moulin L; ; Le Guyader FS; Desdouits M
    Front Microbiol; 2022; 13():889811. PubMed ID: 35756003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Next Generation Sequencing (NGS) data from clinical isolates from the East Texas Region of the United States.
    Carpenter RE; Tamrakar VK; Almas S; Sharma A; Sharma R
    Data Brief; 2023 Aug; 49():109312. PubMed ID: 37346925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing.
    Buenestado-Serrano S; Herranz M; Otero-Sobrino Á; Molero-Salinas A; Rodríguez-Grande C; Sanz-Pérez A; Durán Galván MJ; Catalán P; Alonso R; Muñoz P; Pérez-Lago L; García de Viedma D;
    Int J Med Microbiol; 2024 Mar; 314():151599. PubMed ID: 38290400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing.
    Yan Y; Wu K; Chen J; Liu H; Huang Y; Zhang Y; Xiong J; Quan W; Wu X; Liang Y; He K; Jia Z; Wang D; Liu D; Wei H; Chen J
    Virol Sin; 2021 Oct; 36(5):901-912. PubMed ID: 33851337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilizing cost-effective portable equipment to enhance COVID-19 variant tracking both on-site and at a large scale.
    Park SY; Faraci G; Ward P; Lee HY
    J Clin Microbiol; 2024 Apr; 62(4):e0155823. PubMed ID: 38415638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation.
    Charre C; Ginevra C; Sabatier M; Regue H; Destras G; Brun S; Burfin G; Scholtes C; Morfin F; Valette M; Lina B; Bal A; Josset L
    Virus Evol; 2020 Jul; 6(2):veaa075. PubMed ID: 33318859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
    Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE
    Elife; 2021 Feb; 10():. PubMed ID: 33620031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term monitoring of SARS-CoV-2 variants in wastewater using a coordinated workflow of droplet digital PCR and nanopore sequencing.
    Vigil K; D'Souza N; Bazner J; Cedraz FM; Fisch S; Rose JB; Aw TG
    Water Res; 2024 May; 254():121338. PubMed ID: 38430753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Characterization of SARS-CoV-2 Variants from Clinical Isolates during the COVID-19 Epidemic in Mauritania.
    Deida J; Papa Mze N; Beye M; Ahmed SM; El Bara A; Bollahi MA; Basco L; Ould Mohamed Salem Boukhary A; Fournier PE
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection of SARS-CoV-2 variants through dynamic co-mutation network surveillance.
    Huang Q; Qiu H; Bible PW; Huang Y; Zheng F; Gu J; Sun J; Hao Y; Liu Y
    Front Public Health; 2023; 11():1015969. PubMed ID: 36755900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 complete genome sequencing from the Italian Campania region using a highly automated next generation sequencing system.
    Rachiglio AM; De Sabato L; Roma C; Cennamo M; Fiorenza M; Terracciano D; Pasquale R; Bergantino F; Cavalcanti E; Botti G; Vaccari G; Portella G; Normanno N
    J Transl Med; 2021 Jun; 19(1):246. PubMed ID: 34090468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.